Ardelyx Inc.

Unicycive Therapeutics was started by a single person, went public through an IPO in 2021, and four years later is preparing to continue its track record of proving skeptics wrong by independently lau

The US Food and Drug Administration should consider using a neutral facilitator to chair advisory committee meetings and rethink the lottery process for open public hearing speaking slots. The agency

The US Food and Drug Administration should consider using a neutral facilitator to chair advisory committee meetings and rethink the lottery process for open public hearing speaking slots. The agency

Lykos reiterated its concerns about the “structure and conduct” of the June advisory committee meeting for its MDMA therapy for post-traumatic stress disorder as it prepares to formally challenge the